Education
About Us
Working with TipRanks
Follow Us
MiNK Therapeutics (INKT)
NASDAQ:INKT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -215.44K | $ -204.62K | $ -121.75K | $ -77.96K | $ -55.06K |
| Operating Income | $ -10.65M | $ -22.92M | $ -30.95M | $ -18.61M | $ -10.80M |
| EBITDA | $ -10.57M | $ -22.25M | $ -27.87M | $ -27.70M | $ -13.74M |
| Net Income | $ -10.78M | $ -22.46M | $ -27.99M | $ -30.21M | $ -16.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.58M | $ 3.37M | $ 19.64M | $ 38.89M | $ 2.69M |
| Total Assets | $ 5.72M | $ 4.55M | $ 21.47M | $ 40.24M | $ 4.56M |
| Total Debt | $ 4.92M | $ 0.00 | $ 0.00 | $ 0.00 | $ 43.82M |
| Net Debt | $ 347.57K | $ -3.37M | $ -19.64M | $ -38.89M | $ 41.13M |
| Total Liabilities | $ 25.31M | $ 22.61M | $ 21.87M | $ 16.47M | $ 58.43M |
| Stockholders' Equity | $ -19.59M | $ -18.06M | $ -401.30K | $ 23.78M | $ -53.87M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.56M | $ -15.84M | $ -19.12M | $ -13.08M | $ -8.43M |
| Operating Cash Flow | $ -9.56M | $ -15.76M | $ -18.87M | $ -12.83M | $ -8.34M |
| Investing Cash Flow | $ 0.00 | $ -73.56K | $ -250.05K | $ -248.98K | $ -95.21K |
| Financing Cash Flow | $ 10.82M | $ -407.17K | $ -155.60K | $ 49.26M | $ 11.11M |